Cresco Labs Inc (CRLBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 226,102 | 254,797 | 135,233 | 258,971 | 140,774 |
Receivables | 44,691 | 50,300 | 45,053 | 38,568 | 32,381 |
Inventories | 136,643 | 131,529 | 102,931 | 75,329 | 67,183 |
Other current assets | 3,654 | 12,422 | 10,527 | 8,824 | 9,129 |
TOTAL | $421,755 | $449,048 | $293,744 | $381,692 | $249,467 |
Non-Current Assets | |||||
PPE Net | 369,092 | 344,407 | 298,565 | 250,032 | 228,804 |
Investments And Advances | 5,912 | 6,438 | 9,378 | 11,137 | 4,360 |
Intangibles | 884,411 | 665,329 | 899,670 | 674,950 | 646,110 |
Other Non-Current Assets | 99,293 | 104,716 | 94,054 | 89,321 | 103,855 |
TOTAL | $1,358,708 | $1,120,890 | $1,301,667 | $1,025,440 | $983,129 |
Total Assets | $1,780,463 | $1,569,938 | $1,595,411 | $1,407,132 | $1,232,596 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 19,928 | 15,445 | 28,056 | 28,014 | 25,924 |
Accounts payable and accrued liabilities | 32,278 | 25,617 | 21,985 | 36,999 | 23,231 |
Accrued Expenses | 95,442 | 69,185 | 79,267 | 110,395 | 130,469 |
Other current liabilities | 1,172 | 6,180 | N/A | N/A | N/A |
TOTAL | $288,394 | $209,235 | $194,646 | $276,612 | $252,846 |
Non-Current Liabilities | |||||
Long Term Debt | 465,079 | 463,864 | 264,270 | 258,370 | 255,439 |
Deferred Revenues | 71,833 | 41,892 | 28,297 | 30,565 | 19,115 |
Other Non-Current Liabilities | 4,180 | 831 | 16,396 | 28,752 | 12,613 |
TOTAL | $694,333 | $648,420 | $470,137 | $420,139 | $404,418 |
Total Liabilities | $982,727 | $857,655 | $664,783 | $696,751 | $657,264 |
Shareholders' Equity | |||||
Common Shares | 1,597,715 | 1,483,065 | 1,363,693 | 1,053,209 | 802,264 |
Retained earnings | -841,907 | -813,060 | -534,653 | -443,231 | -328,380 |
Other shareholders' equity | 41,928 | 42,278 | 47,346 | 100,403 | 101,448 |
TOTAL | $797,736 | $712,283 | $930,628 | $710,381 | $575,332 |
Total Liabilities And Equity | $1,780,463 | $1,569,938 | $1,595,411 | $1,407,132 | $1,232,596 |